Polymeric nanomedicines based on poly(lactide) and poly(lactide-co- glycolide)

Current Opinion in Solid State and Materials Science

Volumn 16, Issue 6, 2012, Pages 323-332

  Tong, Rong ^a   Gabrielson, Nathan P ^a   Fan, Timothy M ^b   Cheng, Jianjun ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cancer; Chemotherapeutics; Drug delivery; Nanoconjugates; Nanomedicine; PLA; PLGA; Polymer drug conjugates

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOCONJUGATES; TARGETED DRUG DELIVERY;

BIOCOMPATIBLE POLYESTERS; CANCER; CHEMOTHERAPEUTICS; DRUG DELIVERY TECHNOLOGIES; PHARMACOLOGICAL PROPERTIES; PLGA; POLY-LACTIDE-CO-GLYCOLIDE; POLYMER DRUGS;

CONTROLLED DRUG DELIVERY;

EID: 84875244451     PISSN: 13590286     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cossms.2013.01.001     Document Type: Review

References (131)

1. R. Langer Drug delivery and targeting Nature 392 6679 1998 5 10
2. C. Li, and S. Wallace Polymer-drug conjugates: recent development in clinical oncology Adv Drug Delivery Rev 60 8 2008 886 898
3. I. Collins, and P. Workman New approaches to molecular cancer therapeutics Nat Chem Biol 2 12 2006 689 700
4. R. Duncan Polymer conjugates as anticancer nanomedicines Nat Rev Cancer 6 9 2006 688 701
5. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 3 2005 161 171
6. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 12 2007 751 760
7. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 1-2 2000 271 284
8. R. Duncan Drug polymer conjugates-potential for improved chemotherapy Anti-Cancer Drugs 3 3 1992 175 210
9. H.C. Kolb, M.G. Finn, and K.B. Sharpless Click chemistry: diverse chemical function from a few good reactions Angew Chem Int Ed 40 11 2001 2004 2021
10. S.T. Laughlin, J.M. Baskin, S.L. Amacher, and C.R. Bertozzi In vivo imaging of membrane-associated glycans in developing zebrafish Science 320 5876 2008 664 667
11. K.L. Killops, L.M. Campos, and C.J. Hawker Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene "Click" chemistry J Am Chem Soc 130 15 2008 5062 5064
12. J.A. Champion, Y.K. Katare, and S. Mitragotri Making polymeric micro- and nanoparticles of complex shapes Proc Natl Acad Sci USA 104 29 2007 11901 11904
13. R.S. Kane Fabricating complex polymeric micro- and nanostructures: lithography in microfluidic devices Angew Chem Int Ed 47 8 2008 1368 1370
14. D. Dendukuri, D.C. Pregibon, J. Collins, T.A. Hatton, and P.S. Doyle Continuous-flow lithography for high-throughput microparticle synthesis Nat Mater 5 5 2006 365 369
15. G.M. Gratson, M.J. Xu, and J.A. Lewis Microperiodic structures-direct writing of three-dimensional webs Nature 428 6981 2004 386-86
16. J.R. Heath, and M.E. Davis Nanotechnology and cancer Annu Rev Med 59 2008 251 265
17. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Deliv Rev 55 3 2003 329 347
18. Schmitt EEP, R.A. Polyglycolic acid prosthetic devices. US Patent, 3:463, 158 1967.
19. Z.Y. Zhong, P.J. Dijkstra, and J. Feijen Controlled and stereoselective polymerization of lactide: kinetics, selectivity, and microstructures J Am Chem Soc 125 37 2003 11291 11298
20. M. Cheng, A.B. Attygalle, E.B. Lobkovsky, and G.W. Coates Single-site catalysts for ring-opening polymerization: synthesis of heterotactic poly(lactic acid) from rac-lactide J Am Chem Soc 121 49 1999 11583 11584
21. B.M. Chamberlain, M. Cheng, D.R. Moore, T.M. Ovitt, E.B. Lobkovsky, and G.W. Coates Polymerization of lactide with zinc and magnesium beta-diiminate complexes: stereocontrol and mechanism J Am Chem Soc 123 14 2001 3229 3238
22. O. Dechy-Cabaret, B. Martin-Vaca, and D. Bourissou Controlled ring-opening polymerization of lactide and glycolide Chem Rev 104 12 2004 6147 6176
23. M.H. Chisholm, and N.W. Eilerts Single-site metal alkoxide catalysts for ring-opening polymerizations. Poly(dilactide) synthesis employing {HB(3-Bu(t)pz)(3)}Mg(OEt) Chem Commun 7 1996 853 854
24. K.E. Uhrich, S.M. Cannizzaro, R.S. Langer, and K.M. Shakesheff Polymeric systems for controlled drug release Chem Rev 99 11 1999 3181 3198
25. J. Coudane, C. Ustariz-Peyret, G. Schwach, and M. Vert More about the stereodependence of DD and LL pair linkages during the ring-opening polymerization of racemic lactide J Polym Sci Pol Chem 35 9 1997 1651 1658
26. J.M. Anderson, and M.S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv Drug Deliv Rev 28 1 1997 5 24
27. I. Grizzi, H. Garreau, S. Li, and M. Vert Hydrolytic degradation of devices based on poly(Dl-lactic acid) size-dependence Biomaterials 16 4 1995 305 311
28. M. Vert, J. Mauduit, and S.M. Li Biodegradation of Pla/Ga polymers-increasing complexity Biomaterials 15 15 1994 1209 1213
29. T.G. Park Degradation of poly(lactic-co-glycolic acid) microspheres-effect of copolymer composition Biomaterials 16 15 1995 1123 1130
30. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, and R. Langer Controlled delivery systems for proteins based on poly(lactic glycolic acid) microspheres Pharm Res 8 6 1991 713 720
31. T.G. Park, S. Cohen, and R. Langer Controlled protein release from polyethyleneimine-coated poly(l-lactic acid)/pluronic blend matrices Pharm Res 9 1 1992 37 39
32. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 5153 1994 1600 1603
33. Y.Y. Wang, S.K. Lai, J.S. Suk, A. Pace, R. Cone, and J. Hanes Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier Angew Chem Int Ed 47 50 2008 9726 9729
34. R. Tong, and J. Cheng Anticancer polymeric nanomedicines Polym Rev 47 3 2007 345 381
35. S.D. Putney, and P.A. Burke Improving protein therapeutics with sustained-release formulations Nat Biotechnol 16 2 1998 153 157
36. D. Luo, K. Woodrow-Mumford, N. Belcheva, and W.M. Saltzman Controlled DNA delivery systems Pharm Res 16 8 1999 1300 1308
37. D. Luo, and W.M. Saltzman Synthetic DNA delivery systems Nat Biotechnol 18 1 2000 33 37
38. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. BenJebria, and M.L. Eskew Large porous particles for pulmonary drug delivery Science 276 5320 1997 1868 1871
39. O. Benny, O. Fainaru, A. Adini, F. Cassiola, L. Bazinet, and I. Adini An orally delivered small-molecule formulation with antiangiogenic and anticancer activity Nat Biotechnol 26 7 2008 799 807
40. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, and P.W. Kantoff Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc Natl Acad Sci USA 103 16 2006 6315 6320
41. S. Levenberg, J.S. Golub, M. Amit, J. Itskovitz-Eldor, and R. Langer Endothelial cells derived from human embryonic stem cells Proc Natl Acad Sci USA 99 7 2002 4391 4396
42. S. Levenberg, N.F. Huang, E. Lavik, A.B. Rogers, J. Itskovitz-Eldor, and R. Langer Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds Proc Natl Acad Sci USA 100 22 2003 12741 12746
43. K.A. Woodrow, Y. Cu, C.J. Booth, J.K. Saucier-Sawyer, M.J. Wood, and W.M. Saltzman Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat Mater 8 6 2009 526 533
44. Y. Shi, S. Kim, T.B. Huff, R.B. Borgens, K. Park, and R. Shi Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles Nat Nanotechnol 5 1 2010 80 87
45. A. Khademhosseini, R. Langer, J. Borenstein, and J.P. Vacanti Microscale technologies for tissue engineering and biology Proc Natl Acad Sci USA 103 8 2006 2480 2487
46. A.C.R. Grayson, M.J. Cima, and R. Langer Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance Biomaterials 26 14 2005 2137 2145
47. S.E.A. Gratton, S.S. Williams, M.E. Napier, P.D. Pohlhaus, Z.L. Zhou, and K.B. Wiles The pursuit of a scalable nanofabrication platform for use in material and life science applications Acc Chem Res 41 12 2008 1685 1695
48. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, and M.E. Napier The effect of particle design on cellular internalization pathways Proc Natl Acad Sci USA 105 33 2008 11613 11618
49. J.P. Rolland, B.W. Maynor, L.E. Euliss, A.E. Exner, G.M. Denison, and J.M. DeSimone Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials J Am Chem Soc 127 28 2005 10096 10100
50. N. Doshi, A.S. Zahr, S. Bhaskar, J. Lahann, and S. Mitragotri Red blood cell-mimicking synthetic biomaterial particles Proc Natl Acad Sci USA 2009
51. D.E. Discher, and F. Ahmed Polymersomes Annu Rev Biomed Eng 8 2006 323 341
52. B.M. Discher, Y.Y. Won, D.S. Ege, J.C.M. Lee, F.S. Bates, and D.E. Discher Polymersomes: tough vesicles made from diblock copolymers Science 284 5417 1999 1143 1146
53. Y. Geng, P. Dalhaimer, S.S. Cai, R. Tsai, M. Tewari, and T. Minko Shape effects of filaments versus spherical particles in flow and drug delivery Nat Nanotechnol 2 4 2007 249 255
54. B. Jeong, Y.H. Bae, D.S. Lee, and S.W. Kim Biodegradable block copolymers as injectable drug-delivery systems Nature 388 6645 1997 860 862
55. L. Yu, and J.D. Ding Injectable hydrogels as unique biomedical materials Chem Soc Rev 37 8 2008 1473 1481
56. W.S. Wang, P. Ping, X.S. Chen, and X.B. Jing Polylactide-based polyurethane and its shape-memory behavior Eur Polym J 42 6 2006 1240 1249
57. M. Behl, and A. Lendlein Shape-memory polymers Mater Today 10 4 2007 20 28
58. A. Lendlein, A.M. Schmidt, and R. Langer AB-polymer networks based on oligo(epsilon-caprolactone) segments showing shape-memory properties Proc Natl Acad Sci USA 98 3 2001 842 847
59. A. Lendlein, and R. Langer Biodegradable, elastic shape-memory polymers for potential biomedical applications Science 296 5573 2002 1673 1676
60. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 1 2009 16 20
61. D. Sutton, N. Nasongkla, E. Blanco, and J.M. Gao Functionalized micellar systems for cancer targeted drug delivery Pharm Res 24 6 2007 1029 1046
62. K. Avgoustakis Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr Drug Deliv 1 4 2004 321 333
63. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int J Pharm 55 1 1989 R1 R4
64. J. Cheng, B.A. Teply, I. Sherifi, J. Sung, G. Luther, and F.X. Gu Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28 5 2007 869 876
65. E. Allemann, R. Gurny, and E. Doelker Preparation of aqueous polymeric nanodispersions by a reversible salting-out process-influence of process parameters on particle-size Int J Pharm 87 1-3 1992 247 253
66. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, and S.W. Kim In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J Control Release 72 1-3 2001 191 202
67. T.Y. Kim, D.W. Kim, J.Y. Chung, S.G. Shin, S.C. Kim, and D.S. Heo Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin Cancer Res 10 11 2004 3708 3716
68. K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, and S.B. Kim Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Res Treat 108 2 2008 241 250
69. D.W. Kim, S.Y. Kim, H.K. Kim, S.W. Kim, S.W. Shin, and J.S. Kim Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann Oncol 18 12 2007 2009 2014
70. S.R. Park, D.Y. Oh, D.W. Kim, T.Y. Kim, D.S. Heo, and Y.J. Bang A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer Oncol Rep 12 5 2004 1059 1064
71. H.T. Chen, S.W. Kim, L. Li, S.Y. Wang, K. Park, and J.X. Cheng Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging Proc Natl Acad Sci USA 105 18 2008 6596 6601
72. H.M. Burt, X.C. Zhang, P. Toleikis, L. Embree, and W.L. Hunter Development of copolymers of poly(d, l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel Colloid Surf B-Biointerfaces 16 1-4 1999 161 171
73. H.A. Klok, J.J. Hwang, J.D. Hartgerink, and S.I. Stupp Self-assembling biomaterials: l-lysine-dendron-substituted cholesteryl-(l-lactic acid)(n)over-bar Macromolecules 35 16 2002 6101 6111
74. H.A. Klok, J.J. Hwang, S.N. Iyer, and S.I. Stupp Cholesteryl-(l-lactic acid)((n)over-bar) building blocks for self-assembling biomaterials Macromolecules 35 3 2002 746 759
75. S. Sengupta, D. Eavarone, I. Capila, G.L. Zhao, N. Watson, and T. Kiziltepe Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436 7050 2005 568 572
76. L. Bromberg Polymeric micelles in oral chemotherapy J Control Release 128 2 2008 99 112
77. H.R. Kricheldorf, and I. Kreisersaunders Polylactones.30. vitamins, hormones and drugs as co-initiators of alet(3)-initiated polymerizations of lactide Polymer 35 19 1994 4175 4180
78. J.J. Hwang, S.N. Iyer, L.S. Li, R. Claussen, D.A. Harrington, and S.I. Stupp Self-assembling biomaterials: liquid crystal phases of cholesteryl oligo(l-lactic acid) and their interactions with cells Proc Natl Acad Sci USA 99 15 2002 9662 9667
79. A. Pfister, G. Zhang, J. Zareno, A.F. Horwitz, and C.L. Fraser Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium ACS Nano 2 6 2008 1252 1258
80. G.Q. Zhang, G.M. Palmer, M. Dewhirst, and C.L. Fraser A dual-emissive-materials design concept enables tumour hypoxia imaging Nat Mater 8 9 2009 747 751
81. G. Zhang, J. Chen, S.J. Payne, S.E. Kooi, J.N. Demas, and C.L. Fraser Multi-emissive difluoroboron dibenzoylmethane polylactide exhibiting intense fluorescence and oxygen-sensitive room-temperature phosphorescence J Am Chem Soc 129 29 2007 (8942-+)
82. Z.P. Zhang, and S.S. Feng Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release Biomaterials 27 2 2006 262 270
83. Z.P. Zhang, and S.S. Feng The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles Biomaterials 27 21 2006 4025 4033
84. Z.P. Zhang, S.H. Lee, C.W. Gan, and S.S. Feng In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy Pharm Res 25 8 2008 1925 1935
85. S.S. Feng, L. Mei, P. Anitha, C.W. Gan, and W.Y. Zhou Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel Biomaterials 30 19 2009 3297 3306
86. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R)): PLGA nanoparticles containing vitamin E TPGS J Control Release 86 1 2003 33 48
87. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J Control Release 70 1-2 2001 1 20
88. M. Cheng, D.R. Moore, J.J. Reczek, B.M. Chamberlain, E.B. Lobkovsky, and G.W. Coates Single-site beta-diiminate zinc catalysts for the alternating copolymerization of CO2 and epoxides: catalyst synthesis and unprecedented polymerization activity J Am Chem Soc 123 36 2001 8738 8749
89. 2 and propylene oxide J Am Chem Soc 124 48 2002 14284 14285
90. 2/epoxide polymerization: subtle modifications resulting in superior activities Angew Chem Int Ed 41 14 2002 2599 2602
91. T.M. Ovitt, and G.W. Coates Stereochemistry of lactide polymerization with chiral catalysts: new opportunities for stereocontrol using polymer exchange mechanisms J Am Chem Soc 124 7 2002 1316 1326
92. L.R. Rieth, D.R. Moore, E.B. Lobkovsky, and G.W. Coates Single-site beta-diiminate zinc catalysts for the ring-opening polymerization of beta-butyrolactone and beta-valerolactone to poly(3-hydroxyalkanoates) J Am Chem Soc 124 51 2002 15239 15248
93. R. Tong, and J. Cheng Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles Angew Chem Int Ed 47 26 2008 4830 4834
94. R. Tong, and J. Cheng Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles J Am Chem Soc 131 13 2009 4744 4754
95. R.P. Hertzberg, M.J. Caranfa, and S.M. Hecht On the mechanism of topoisomerase-I inhibition by camptothecin-evidence for binding to an enzyme DNA complex Biochemistry 28 11 1989 4629 4638
96. F.M. Muggia, I. Dimery, and S.G. Arbuck Camptothecin and its analogs-an overview of their potential in cancer therapeutics Ann NY Acad Sci 1996
97. M.L. Rothenberg, and I. Topoisomerase Inhibitors: review and update Ann Oncol 8 9 1997 837 855
98. J. Cheng, K.T. Khin, G.S. Jensen, A.J. Liu, and M.E. Davis Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates Bioconjugate Chem 14 5 2003 1007 1017
99. R.B. Greenwald, A. Pendri, C. Conover, C. Gilbert, R. Yang, and J. Xia Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol)ester transport forms J Med Chem 39 10 1996 1938 1940
100. 2 using beta-diiminate zinc catalysts: evidence for a bimetallic epoxide enchainment J Am Chem Soc 125 39 2003 11911 11924
101. R. Tong, and J. Cheng Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates Bioconjugate Chem 21 1 2010 111 121
102. D. Mastropaolo, A. Camerman, Y.G. Luo, G.D. Brayer, and N. Camerman Crystal and molecular-structure of paclitaxel (taxol) Proc Natl Acad Sci USA 92 15 1995 6920 6924
103. T.C. Boge, R.H. Himes, D.G. Vandervelde, and G.I. Georg The effect of the aromatic rings of taxol on biological-activity and solution conformation-synthesis and evaluation of saturated taxol and taxotere analogs J Med Chem 37 20 1994 3337 3343
104. N.F. Magri, and D.G.I. Kingston Modified taxols. 2. Oxidation-products of taxol J Org Chem 51 6 1986 797 802
105. R. Tong, and J. Cheng Drug-initiated, controlled ring-opening polymerization for the synthesis of polymer-drug conjugates Macromolecules 45 5 2012 2225 2232
106. F. Kratz, U. Beyer, and M.T. Schutte Drug-polymer conjugates containing acid-cleavable bonds Crit Rev Ther Drug Carrier Syst 16 3 1999 245 288
107. K. Ulbrich, and V. Subr Polymeric anticancer drugs with pH-controlled activation Adv Drug Deliv Rev 56 7 2004 1023 1050
108. E.R. Gillies, and J.M.J. Frechet PH-responsive copolymer assemblies for controlled release of doxorubicin Bioconjugate Chem 16 2 2005 361 368
109. C.C. Lee, A.T. Cramer, F.C. Szoka, and J.M.J. Frechet An intramolecular cyclization reaction is responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin Bioconjugate Chem 17 5 2006 1364 1368
110. C.C. Lee, E.R. Gillies, M.E. Fox, S.J. Guillaudeu, J.M.J. Frechet, and E.E. Dy A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas Proc Natl Acad Sci USA 103 45 2006 16649 16654
111. T. Kaneko, D. Willner, I. Monkovic, J.O. Knipe, G.R. Braslawsky, and R.S. Greenfield New hydrazone derivatives of adriamycin and their immunoconjugates-a correlation between acid stability and cytotoxicity Bioconjugate Chem 2 3 1991 133 141
112. R.S. Greenfield, A. Daues, M.A. Edson, S. Gawlak, K. Fitzgeraldkadow, and G.L. Spitalny Optimization of immunotherapy with adriamycin(hydrazone)- immunoconjugates in human B-lymphoma xenografts Antibody Immunoconj Radiopharm 4 2 1991 107 119
113. R.S. Greenfield, T. Kaneko, A. Daues, M.A. Edson, K.A. Fitzgerald, and L.J. Olech Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker Cancer Res 50 20 1990 6600 6607
114. G.R. Braslawsky, M.A. Edson, W. Pearce, T. Kaneko, and R.S. Greenfield Antitumor-activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor-cell killing Cancer Res 50 20 1990 6608 6614
115. J.C. Florent, and C. Monneret Doxorubicin conjugates for selective delivery to tumors Anthracycline Chem Biol Ii: Mode Action, Clin Aspects New Drugs 283 2008 99 140
116. F. Meyer-Losic, J. Quinonero, V. Dubois, B. Alluis, M. Dechambre, and M. Michel Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell) J Med Chem 49 23 2006 6908 6916
117. D.H. Altreuter, J.S. Dordick, and D.S. Clark Nonaqueous biocatalytic synthesis of new cytotoxic doxorubicin derivatives: exploiting unexpected differences in the regioselectivity of salt-activated and solubilized subtilisin J Am Chem Soc 124 9 2002 1871 1876
118. M.H. Chisholm, J. Gallucci, and K. Phomphrai Coordination chemistry and reactivity of monomeric alkoxides and amides of magnesium and zinc supported by the diiminato ligand CH(CMeNC6H3-2,6-Pr-i(2))(2). A comparative study Inorg Chem 41 10 2002 2785 2794
119. T. Musumeci, C.A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, and R. Pignatello PLA/PLGA nanoparticles for sustained release of docetaxel Int J Pharm 325 1-2 2006 172 179
120. Y. Barenholz Relevancy of drug loading to liposomal formulation therapeutic efficacy J Lipos Res 2003 1 8
121. K.J. Hamblett, P.D. Senter, D.F. Chace, M.M.C. Sun, J. Lenox, and C.G. Cerveny Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate Clin Cancer Res 10 20 2004 7063 7070
122. J. Cheng, K.T. Khin, and M.E. Davis Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates Mol Pharm 1 3 2004 183 193
123. D. Missirlis, R. Kawamura, N. Tirelli, and J.A. Hubbell Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles Eur J Pharm Sci 29 2 2006 120 129
124. Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, and Y. Shimada Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin Br J Cancer 91 10 2004 1775 1781
125. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat Rev Clin Oncol 7 11 2010 653 664
126. S.M. Nimjee, C.P. Rusconi, and B.A. Sullenger Aptamers: an emerging class of therapeutics Annu Rev Med 56 2005 555 583
127. C. Wilson, and J.W. Szostak Isolation of a fluorophore-specific DNA aptamer with weak redox activity Chem Biol 5 11 1998 609 617
128. O.C. Farokhzad, S.Y. Jon, A. Khadelmhosseini, T.N.T. Tran, D.A. LaVan, and R. Langer Nanopartide-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Res 64 21 2004 7668 7672
129. Z.H. Cao, R. Tong, A. Mishra, W.C. Xu, G.C.L. Wong, and J. Cheng Reversible cell-specific drug delivery with aptamer-functionalized liposomes Angew Chem Int Ed 48 35 2009 6494 6498
130. R. Tong, L. Yala, T.M. Fan, and J. Cheng The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells Biomaterials 31 11 2010 3043 3053
131. F. Alexis, P. Basto, E. Levy-Nissenbaum, A.F. Radovic-Moreno, L. Zhang, and E. Pridgen HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy ChemMedChem 3 12 2008 1839 1843